Resource Center

Jul 1, 2015
  |  White Paper

Virtual tests for new therapies (From Bayer Research)

When researchers design a new drug product, they have to know exactly what will happen to the active ingredient once it is inside the body. For this, they are increasingly turning to computer-based predictions and virtual patients. Scientists at Bayer are collaborating with external partners on innovative methods to better predict the safety of new drug candidates and thus make drug development even more effective.

Contact Us About This White Paper